Neuropathic pain syndrome is a challenge to treat and, even with appropriate evidence-based treatment, only a 40% reduction of symptoms can be achieved in approximately half of patients.

Finnerup NB, Kuner R, Jensen TS: Neuropathic pain: from mechanisms to treatment. Physiol Rev 2021; 101: 259–301 CrossRef MEDLINE 9. Gangadharan V, Zheng H, Taberner FJ, et al.: Neuropathic pain ...

Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics ...

The following is a summary of “A Double-Blind Comparative Study of burstDR Versus Tonic Epidural Motor Cortex Stimulation for ...

THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 - Changing the Paradigm for ...